Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
04/2003
04/03/2003US20030064994 Substituted alkyl piperazine derivatives
04/03/2003CA2461087A1 Process for the preparation of repaglinide
04/02/2003EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen
04/02/2003EP1296983A1 Novel process for the preparation of pyrazolopyrimidinones
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP0944609B1 Process for preparing n-alkyl ammonium acetonitrile compounds
04/02/2003CN1407981A Method for producing 5-(1piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
04/02/2003CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
04/02/2003CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541479 Calcium channel blockers
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541476 Piperazine derivatives and their use as anti-inflammatory agents
04/01/2003US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
04/01/2003US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist
03/2003
03/28/2003WO2002030869A1 5-amino-1-pentene-3-ol substituted derivatives
03/28/2003CA2424103A1 Substituted 5-amino-1-penten-3-ol derivatives
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024945A2 Method for producing polyphosphates of organic bases
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024923A1 Sulfonamide compounds as protease inhibitors
03/27/2003WO2003024913A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY
03/27/2003WO2003024591A1 Modified alumina catalyst
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002030915A3 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport
03/27/2003US20030060632 Aniline derivatives to treat stroke, cerebral ischemia, head trauma, or epilepsy
03/27/2003US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060472 Inhibitor of the enzyme catechol-O-methyl transferase (COMT)
03/27/2003US20030060465 Such as 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid morpholinocarbonyloxyethyl ester; for reducing gastrointestinal side effects
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460125A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003CA2459546A1 Modified alumina catalyst
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295876A1 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/26/2003EP1295871A1 Vitamin d derivatives
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1295608A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/26/2003EP1294682A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
03/26/2003EP1294657A2 Catalysis using phosphine oxide and sulfoxide compounds
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/25/2003US6538159 For use in protecting plants against infestation by phytopathogenic microorganisms
03/25/2003US6538141 Method for preparing nitroxides
03/25/2003US6537329 Intense colorations with a wide range of colours, excellent colorfastness
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022815A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002072545A3 9-aminoacyl tetracycline compounds and methods of use thereof
03/20/2003US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055064 Piperazine compounds and medicinal use thereof
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003US20030054395 Isolation of nucleic acids
03/20/2003US20030054200 Organic electroluminescence device
03/20/2003CA2459879A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
03/19/2003EP1292599A1 Solutions of lithium pyrrolidine in tetrahydrofuran (thf)/hydrocarbons
03/19/2003EP1292586A1 Process for the preparation of pyrazolopyrimidinones
03/19/2003EP1292575A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003EP0956141B1 Amine heat stable salt neutralization having reduced solids
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404471A Substituted piperazine compounds
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1403449A Prepn of acetyl morphine
03/19/2003CN1403448A Process for producing 2-(4-alkyl-1-piperazyl)-benzaldehyde and-benzal compound
03/19/2003CN1103333C Selective thrombin inhibitors
03/18/2003WO2002024637A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents
03/18/2003US6534545 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534499 For therapy of autoimmune disease
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534441 Nickel-rhenium catalyst for use in reductive amination processes
03/18/2003US6533960 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst